Tango Therapeutics

Tango Therapeutics

MA - Cambridge
Biotechnology

Focus: Cancer Therapeutics, Immuno-Oncology

Tango Therapeutics is a life sciences company focused on Cancer Therapeutics, Immuno-Oncology.

Oncology
Open Jobs
10

Pipeline & Clinical Trials

Clinical Trials (1)
NCT05887492Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Phase 1/2
Clinical Trials (1)
NCT06188702S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Phase 1/2
Clinical Trials (1)
NCT05732831Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/2
Clinical Trials (1)
NCT05275478Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06065059Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Phase 1/2
Clinical Trials (1)
NCT06810544Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Phase 1/2
TNG462
PDAC
Phase 1/2
Clinical Trials (1)
NCT06922591Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Phase 1/2

Open Jobs (10)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
Top TAs: Oncology
Open Roles: 10 active jobs
Therapeutic Area Focus
Oncology
6 pipeline
Marketed
Pipeline

Hiring Trend

Stable
10
Open Roles
+0
Added
-1
Filled/Removed

Based on last 4 crawl cycles